-
1
-
-
16544371710
-
Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration
-
Talarico L, Chen G, Pazdur R: Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004, 22:4626-31.
-
(2004)
J Clin Oncol
, vol.22
, pp. 4626-4631
-
-
Talarico, L.1
Chen, G.2
Pazdur, R.3
-
2
-
-
0030657918
-
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: A report from the Italian Group for the Study of Digestive Tract Cancer
-
Cascinu S, Labianca R, Alessandroni P, Marcellini M, Silva RR, Pancera G, Testa E, Martignoni G, Barni S, Frontini L, Zaniboni A, Luporini G, Cellerino R, Catalano G: Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol 1997, 11:3313-3319.
-
(1997)
J Clin Oncol
, vol.11
, pp. 3313-3319
-
-
Cascinu, S.1
Labianca, R.2
Alessandroni, P.3
Marcellini, M.4
Silva, R.R.5
Pancera, G.6
Testa, E.7
Martignoni, G.8
Barni, S.9
Frontini, L.10
Zaniboni, A.11
Luporini, G.12
Cellerino, R.13
Catalano, G.14
-
3
-
-
2442494952
-
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: A report from the Italian Group for the Study of Digestive Tract Cancer [GIS-CAD]
-
Cascinu S, Scartozzi M, Labianca R, Catalano V, Silva RR, Barni S, Zaniboni A, D'Angelo A, Salvagni S, Martignoni G, Beretta GD, Graziano F, Berardi R, Franciosi V: High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer [GIS-CAD]. Br J Cancer 2004, 8:1521-5.
-
(2004)
Br J Cancer
, vol.8
, pp. 1521-1525
-
-
Cascinu, S.1
Scartozzi, M.2
Labianca, R.3
Catalano, V.4
Silva, R.R.5
Barni, S.6
Zaniboni, A.7
D'Angelo, A.8
Salvagni, S.9
Martignoni, G.10
Beretta, G.D.11
Graziano, F.12
Berardi, R.13
Franciosi, V.14
-
4
-
-
0242575737
-
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer
-
Graziano F, Santini D, Testa E, Catalano V, Beretta GD, Mosconi S, Tonini G, Lai V, Labianca R, Cascinu S: A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer. Br J Cancer 2003, 8:1428-32.
-
(2003)
Br J Cancer
, vol.8
, pp. 1428-1432
-
-
Graziano, F.1
Santini, D.2
Testa, E.3
Catalano, V.4
Beretta, G.D.5
Mosconi, S.6
Tonini, G.7
Lai, V.8
Labianca, R.9
Cascinu, S.10
-
6
-
-
1442307855
-
Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer
-
Al-Batran SE, Atmaca A, Hegewisch-Becker S, Jaeger D, Hahnfeld S, Rummel MJ, Seipelt G, Rost A, Orth J, Knuth A, Jaeger E: Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol 2004, 4:658-63.
-
(2004)
J Clin Oncol
, vol.4
, pp. 658-663
-
-
Al-Batran, S.E.1
Atmaca, A.2
Hegewisch-Becker, S.3
Jaeger, D.4
Hahnfeld, S.5
Rummel, M.J.6
Seipelt, G.7
Rost, A.8
Orth, J.9
Knuth, A.10
Jaeger, E.11
-
7
-
-
4243135036
-
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
-
Chao Y, Yeh KH, Chang CJ, Chen LT, Chao TY, Wu MF, Chang CS, Chang JY, Chung CY, Kao WY, Hsieh RK, Cheng AL: Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer. Br J Cancer 2004, 3:453-8.
-
(2004)
Br J Cancer
, vol.3
, pp. 453-458
-
-
Chao, Y.1
Yeh, K.H.2
Chang, C.J.3
Chen, L.T.4
Chao, T.Y.5
Wu, M.F.6
Chang, C.S.7
Chang, J.Y.8
Chung, C.Y.9
Kao, W.Y.10
Hsieh, R.K.11
Cheng, A.L.12
-
8
-
-
21144476975
-
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid [FOLFOX-4] as first-line treatment of advanced gastric cancer patients
-
De Vita F, Orditura M, Matano E, Bianco R, Carlomagno C, Infusino S, Damiano V, Simeone E, Diadema MR, Lieto E, Castellano P, Pepe S, De Placido S, Galizia G, Di Martino N, Ciardiello F, Catalano G, Bianco AR: A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid [FOLFOX-4] as first-line treatment of advanced gastric cancer patients. Br J Cancer 2005, 9:1644-9.
-
(2005)
Br J Cancer
, vol.9
, pp. 1644-1649
-
-
De Vita, F.1
Orditura, M.2
Matano, E.3
Bianco, R.4
Carlomagno, C.5
Infusino, S.6
Damiano, V.7
Simeone, E.8
Diadema, M.R.9
Lieto, E.10
Castellano, P.11
Pepe, S.12
De Placido, S.13
Galizia, G.14
Di Martino, N.15
Ciardiello, F.16
Catalano, G.17
Bianco, A.R.18
-
9
-
-
0036893770
-
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients
-
Louvet C, Andre T, Tigaud JM, Gamelin E, Douillard JY, Brunet R, Francois E, Jacob JH, Levoir D, Taamma A, Rougier P, Cvitkovic E, de Gramont A: Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol 2002, 20:4543-4548.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4543-4548
-
-
Louvet, C.1
Andre, T.2
Tigaud, J.M.3
Gamelin, E.4
Douillard, J.Y.5
Brunet, R.6
Francois, E.7
Jacob, J.H.8
Levoir, D.9
Taamma, A.10
Rougier, P.11
Cvitkovic, E.12
de Gramont, A.13
-
10
-
-
23744457430
-
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid [FUFOX regimen] as first-line treatment in metastatic gastric cancer
-
Lordick F, Lorenzen S, Stollfuss J, Vehling-Kaiser U, Kullmann F, Hentrich M, Zumschlinge R, Dietzfelbinger H, Thoedtmann J, Hennig M, Seroneit T, Bredenkamp R, Duyster J, Peschel C: Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid [FUFOX regimen] as first-line treatment in metastatic gastric cancer. Br J Cancer 2005, 93:190-4.
-
(2005)
Br J Cancer
, vol.93
, pp. 190-194
-
-
Lordick, F.1
Lorenzen, S.2
Stollfuss, J.3
Vehling-Kaiser, U.4
Kullmann, F.5
Hentrich, M.6
Zumschlinge, R.7
Dietzfelbinger, H.8
Thoedtmann, J.9
Hennig, M.10
Seroneit, T.11
Bredenkamp, R.12
Duyster, J.13
Peschel, C.14
-
11
-
-
21244437063
-
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
-
Sumpter K, Harper-Wynne C, Cunningham D, Rao S, Tebbutt N, Norman AR, Ward C, Iveson T, Nicolson M, Hickish T, Hill M, Oates J: Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. Br J Cancer 2005, 92:1976-83.
-
(2005)
Br J Cancer
, vol.92
, pp. 1976-1983
-
-
Sumpter, K.1
Harper-Wynne, C.2
Cunningham, D.3
Rao, S.4
Tebbutt, N.5
Norman, A.R.6
Ward, C.7
Iveson, T.8
Nicolson, M.9
Hickish, T.10
Hill, M.11
Oates, J.12
-
12
-
-
0030935080
-
Functional health status as a predictor of mortality in men and women over 65
-
Scott WK, Macera CA, Cornman CB, Sharpe PA: Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol 1997, 50:291-296.
-
(1997)
J Clin Epidemiol
, vol.50
, pp. 291-296
-
-
Scott, W.K.1
Macera, C.A.2
Cornman, C.B.3
Sharpe, P.A.4
-
13
-
-
0034327146
-
General guidelines for management of older patients with cancer
-
Balducci L, Yates J: General guidelines for management of older patients with cancer. Oncology 2000, 14:221-227.
-
(2000)
Oncology
, vol.14
, pp. 221-227
-
-
Balducci, L.1
Yates, J.2
-
14
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 3:205-16.
-
(2000)
J Natl Cancer Inst
, vol.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
van Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
16
-
-
0025213358
-
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer: A phase II study in elderly patients or patients with cardiac risk
-
Wilke H, Preusser P, Fink U, Achterrath W, Lenaz L, Stahl M, Schober C, Link H, Meyer HJ, Lucke B: High dose folinic acid/etoposide/ 5-fluorouracil in advanced gastric cancer: a phase II study in elderly patients or patients with cardiac risk. Invest New Drugs 1990, 8:65-70.
-
(1990)
Invest New Drugs
, vol.8
, pp. 65-70
-
-
Wilke, H.1
Preusser, P.2
Fink, U.3
Achterrath, W.4
Lenaz, L.5
Stahl, M.6
Schober, C.7
Link, H.8
Meyer, H.J.9
Lucke, B.10
-
17
-
-
0028284056
-
Etoposide, leucovorin 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: A pilot study
-
Cascinu S, Fedeli A, Catalano G: Etoposide, leucovorin 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study. Cancer Chemother Pharmacol 1994, 34:72-74.
-
(1994)
Cancer Chemother Pharmacol
, vol.34
, pp. 72-74
-
-
Cascinu, S.1
Fedeli, A.2
Catalano, G.3
-
18
-
-
0029013091
-
Intensive weekly chemotherapy for elderly gastric cancer patients using 5-fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin and gluthatione with the support of G-CSF
-
Cascinu G, Catalano G: Intensive weekly chemotherapy for elderly gastric cancer patients using 5-fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin and gluthatione with the support of G-CSF. Tumori 1995, 81:32-35.
-
(1995)
Tumori
, vol.81
, pp. 32-35
-
-
Cascinu, G.1
Catalano, G.2
-
19
-
-
0028876887
-
Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy
-
Di Bartolomeo M, Bajetta E, de Braud F, Bochicchio AM, Gebbia V, Bozzetti F, Doci R, Bonfanti G, Cozzaglio L: Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy. Oncology 1995, 52:41-44.
-
(1995)
Oncology
, vol.52
, pp. 41-44
-
-
Di Bartolomeo, M.1
Bajetta, E.2
de Braud, F.3
Bochicchio, A.M.4
Gebbia, V.5
Bozzetti, F.6
Doci, R.7
Bonfanti, G.8
Cozzaglio, L.9
-
20
-
-
0033646752
-
Combination of bolus 5-fluorouracil, folinic acid and mitomycin-C in advanced gastric cancer: Results of a phase II trial
-
Hartung G, Hofheinz R, Buchheidt D, Rost A, Brecht A, Forche K, Schroder M, Wojatschek C, Fritze D, Hehlmann R, Queisser W: Combination of bolus 5-fluorouracil, folinic acid and mitomycin-C in advanced gastric cancer: results of a phase II trial. Onkologie 2000, 23:444-447.
-
(2000)
Onkologie
, vol.23
, pp. 444-447
-
-
Hartung, G.1
Hofheinz, R.2
Buchheidt, D.3
Rost, A.4
Brecht, A.5
Forche, K.6
Schroder, M.7
Wojatschek, C.8
Fritze, D.9
Hehlmann, R.10
Queisser, W.11
-
21
-
-
0036516622
-
A phase II study of doxifluridine in elderly patients with advanced gastric cancer: The Japan Clinical Oncology Group study [JCOG 9410]
-
Ikeda N, Shimada Y, Ohtsu A, Boku N, Tsuji Y, Saito H, Koizumi W, Iwase H, Yoshida S, Fukuda H: A phase II study of doxifluridine in elderly patients with advanced gastric cancer: the Japan Clinical Oncology Group study [JCOG 9410]. Jpn J Clin Oncol 2002, 32:90-94.
-
(2002)
Jpn J Clin Oncol
, vol.32
, pp. 90-94
-
-
Ikeda, N.1
Shimada, Y.2
Ohtsu, A.3
Boku, N.4
Tsuji, Y.5
Saito, H.6
Koizumi, W.7
Iwase, H.8
Yoshida, S.9
Fukuda, H.10
-
22
-
-
0037352255
-
Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer
-
Kim DY, Kim JH, Lee SH, Kim TY, Heo DS, Bang YJ, Kim NK: Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer. Ann Oncol 2003, 14:383-387.
-
(2003)
Ann Oncol
, vol.14
, pp. 383-387
-
-
Kim, D.Y.1
Kim, J.H.2
Lee, S.H.3
Kim, T.Y.4
Heo, D.S.5
Bang, Y.J.6
Kim, N.K.7
-
23
-
-
0032921628
-
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: Results of a randomized trial
-
Waters JS, Norman A, Cunningham D, Scarffe JH, Webb A, Harper P, Joffe JK, Mackean M, Mansi J, Leahy M, Hill A, Oates J, Rao S, Nicolson M, Hickish T: Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: Results of a randomized trial. Br J Cancer 1999, 80:269-272.
-
(1999)
Br J Cancer
, vol.80
, pp. 269-272
-
-
Waters, J.S.1
Norman, A.2
Cunningham, D.3
Scarffe, J.H.4
Webb, A.5
Harper, P.6
Joffe, J.K.7
Mackean, M.8
Mansi, J.9
Leahy, M.10
Hill, A.11
Oates, J.12
Rao, S.13
Nicolson, M.14
Hickish, T.15
-
24
-
-
21144476975
-
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid [FOLFOX-4] as first-line treatment of advanced gastric cancer patients
-
De Vita F, Orditura M, Matano E, Bianco R, Carlomagno C, Infusino S, Damiano V, Simeone E, Diadema MR, Lieto E, Castellano P, Pepe S, De Placido S, Galizia G, Di Martino N, Ciardiello F, Catalano G, Bianco AR: A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid [FOLFOX-4] as first-line treatment of advanced gastric cancer patients. Br J Cancer 2005, 92:1644-9.
-
(2005)
Br J Cancer
, vol.92
, pp. 1644-1649
-
-
De Vita, F.1
Orditura, M.2
Matano, E.3
Bianco, R.4
Carlomagno, C.5
Infusino, S.6
Damiano, V.7
Simeone, E.8
Diadema, M.R.9
Lieto, E.10
Castellano, P.11
Pepe, S.12
De Placido, S.13
Galizia, G.14
Di Martino, N.15
Ciardiello, F.16
Catalano, G.17
Bianco, A.R.18
-
25
-
-
0031022803
-
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
-
Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underhill C, Wardley A, Meehan M: Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997, 15:261-267.
-
(1997)
J Clin Oncol
, vol.15
, pp. 261-267
-
-
Webb, A.1
Cunningham, D.2
Scarffe, J.H.3
Harper, P.4
Norman, A.5
Joffe, J.K.6
Hughes, M.7
Mansi, J.8
Findlay, M.9
Hill, A.10
Oates, J.11
Nicolson, M.12
Hickish, T.13
O'Brien, M.14
Iveson, T.15
Watson, M.16
Underhill, C.17
Wardley, A.18
Meehan, M.19
-
26
-
-
0033909505
-
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
-
Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, Van Cutsem E, Flanker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B, Wils JA: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 2000, 18:2648-2657.
-
(2000)
J Clin Oncol
, vol.18
, pp. 2648-2657
-
-
Vanhoefer, U.1
Rougier, P.2
Wilke, H.3
Ducreux, M.P.4
Lacave, A.J.5
Van Cutsem, E.6
Flanker, M.7
Santos, J.G.8
Piedbois, P.9
Paillot, B.10
Bodenstein, H.11
Schmoll, H.J.12
Bleiberg, H.13
Nordlinger, B.14
Couvreur, M.L.15
Baron, B.16
Wils, J.A.17
|